Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WNT9A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GOLGA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00964 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CEACAM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLP1R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
AKT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCR8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAZ1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC57 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506882 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOB1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAMBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERINC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM59 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASGRP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADCY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on